Page 167 - CW E-Magazine (1-7-2025)

News from Abroad

PARTNERSHIP

Integrals Power inks battery materials sourcing deal

with Euro Manganese

Integrals Power, a UK-based battery Powers’ pilot line in the UK. This will of this year. Following the successful
nano-material company, is strengthen- enable Integrals Power to continue completion of the tests, the letter of
ing the supply chain for its Lithium scaling-up capacity from the current intent signed by both companies will
Manganese Iron Phosphate (LMFP) 20 tonnes a year to mass-production as see supply of the HPMSM for an initial
cathode active materials. it commercialises its LMFP technology. term of seven years, with the option to
Demand for LMFP, particularly for renew for additional successive four-
The company is partnering with electric vehicle batteries, is expected to year periods. Euro Manganese will
Canada’s Euro Manganese to secure increase in the coming years because it produce the HPMSM at its Czech
a supply of high purity Manganese enables comparable range to Nickel Republic facility using old tailings from
Sulphate Monohydrate (HPMSM) – a Manganese Cobalt cell chemistries but a decommissioned mine. Recycling a
critical raw material for the battery for significantly less cost and with greater by-product in this way will help to lower
sector, and which China accounts for levels of safety and thermal stability. batteries’ carbon footprint and envi-
more than 90% of production. ronmental impact. These attributes will
Testing to determine compatibility become even more important with the
Euro Manganese will produce of Euro Manganese’s HPMSM with introduction from 2027 of EU Battery
HPMSM in a facility in the Czech Integrals Power’s production process and Passport regulations, which will track
Republic – which will be the only source the performance of the resulting LMFP the full lifecycle of every EV battery
within Europe – and ship it to Integrals materials will begin in the third quarter sold in the EU market.

BASF boosts biopharma capabilities in US

BASF has opened a new Good
Manufacturing Practice (GMP) Solu-
tion Centre, in Wyandotte, Michigan,
US.

The company said the investment
will help provide innovative solutions
in the biopharma and pharmaceutical
ingredients industries, including the
supply of bioprocessing ingredients
and excipients for biopharma applica-
tions as well as small molecules.

Featuring state-of-the-art clean room
packaging, and high-sensitivity analy-
tical testing, this new facility enables
close collaboration with customers on Commenting on the development, industries. This state-of-the-art facility
customised chemistries for product Ms. Marion Kuhn, vice president of will play a fundamental role in enabling
development. Additionally, improved business management, BASF Pharma us to collaborate closely with our cus-
manufacturing capabilities will allow Solutions said, “Our new GMP Solu- tomers worldwide on product develop-
for more tightly controlled parameters tion Centre exemplifies BASF’s dedi- ment and GMP manufacturing in ways
beyond compendial limits and a validated cation to understanding and addressing that are unique to the industry, further
control system that allows for high re- the evolving needs of our customers in strengthening our position as an inno-
productivity, the company said. both the biopharma and pharmaceutical vator in the pharmaceutical sector.”

Chemical Weekly July 1, 2025 167

Contents Index to Advertisers Index to Products Advertised